{"id":12250,"date":"2024-11-28T08:00:06","date_gmt":"2024-11-28T07:00:06","guid":{"rendered":"https:\/\/fei-online.com\/?p=12250"},"modified":"2024-11-27T11:52:18","modified_gmt":"2024-11-27T10:52:18","slug":"miura-partners-acquires-citrus-flavonoid-manufacturer-htba","status":"publish","type":"post","link":"https:\/\/fei-online.com\/miura-partners-acquires-citrus-flavonoid-manufacturer-htba\/","title":{"rendered":"Miura Partners acquires citrus flavonoid manufacturer HTBA"},"content":{"rendered":"
\n

\r\n\r\n\"LUBRIPLATE\"<\/a>\r\n<\/p>\n<\/div><\/section><\/div>

<\/p>\n<\/div><\/section>
\n

Miura Partners acquires citrus flavonoid manufacturer HTBA<\/h1>acquisition<\/a><\/span>, citrus<\/a><\/span>, E-News<\/a>, Industry News<\/a>, Ingredients<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\n

Spanish bioactives specialist HealthTech BioActives (HTBA) reports substantial growth over the past five years, with revenues reaching \u20ac80 million and workforce doubling to 200 employees. The Barcelona-based manufacturer of citrus flavonoids and vitamin B12 derivatives will now pursue further expansion under new majority shareholder Miura Partners.<\/strong><\/p>\n

<\/p>\n

The company operates a research, development and production facility in Beniel, Murcia, alongside its Barcelona headquarters and North American subsidiary in Cincinnati, Ohio. These facilities focus on manufacturing naturally-derived ingredients for pharmaceutical, nutraceutical, food and beverage applications.<\/p>\n

\"HTBA<\/p>\n

Revenue growth<\/strong><\/h3>\n

Under previous owner The Riverside Company, HTBA achieved a 66% increase in annual revenue since 2019, reaching \u20ac80 million. The company\u2019s workforce has expanded proportionally, doubling to 200 employees across its international operations during the same period.<\/p>\n

Technical capabilities<\/strong><\/h3>\n

HTBA specialises in four key business areas: Functional Health, Pharmaceutical Active Ingredients (APIs), Taste Modulation, and Animal Nutrition. The company has developed proprietary processes for extracting and purifying citrus flavonoids and producing active forms of vitamin B12.<\/p>\n

Commenting on the acquisition, HTBA Chief Executive Officer Alexandre Valls-Coma said: \u201cThe agreement of our new shareholder structure with Miura Partners is an important milestone for HTBA, reinforcing our position as a rising star in the health and nutrition industry.\u201d<\/p>\n

He added: \u201cWe remain fully focused on our mission of unlocking the power of nature through our proprietary processes and high-purity ingredients, with a genuine commitment to sustainability. Staying true to these principles has enabled us to enhance the health and well-being of both people and animals for over 40 years.\u201d<\/p>\n

Research focus<\/strong><\/h3>\n

The company maintains ideation centres at both its Spanish headquarters and Ohio facility, enabling rapid response to changes in consumer demands across global markets. These research capabilities support HTBA\u2019s forty-year track record in developing new processes for creating naturally-derived ingredients whilst maintaining environmental protection standards.<\/p>\n

The acquisition by Miura Partners positions HTBA to pursue further international expansion, building on its established presence in both European and North American markets.<\/p>\n<\/div><\/section>
\n